Redhill Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RDHL and other ETFs, options, and stocks.About RDHL
RedHill Biopharma Ltd. engages in the development and commercialization of drugs for gastrointestinal (GI), infectious diseases, and oncology. The firm's products include Talicia, Movantik, and Aemcolo.
CEODror Ben-Asher
CEODror Ben-Asher
Employees35
Employees35
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2009
Founded2009
Employees35
Employees35
RDHL Key Statistics
Market cap5.43M
Market cap5.43M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume68.12K
Average volume68.12K
High today$1.26
High today$1.26
Low today$1.17
Low today$1.17
Open price$1.17
Open price$1.17
Volume42.23K
Volume42.23K
52 Week high$8.37
52 Week high$8.37
52 Week low$1.01
52 Week low$1.01
Stock Snapshot
With a market cap of 5.43M, Redhill Biopharma(RDHL) trades at $1.19. The stock has a price-to-earnings ratio of -0.02.
As of 2025-12-09, Redhill Biopharma(RDHL) stock has fluctuated between $1.17 and $1.26. The current price stands at $1.19, placing the stock +1.7% above today's low and -5.5% off the high.
Redhill Biopharma(RDHL) shares are trading with a volume of 42.23K, against a daily average of 68.12K.
In the last year, Redhill Biopharma(RDHL) shares hit a 52-week high of $8.37 and a 52-week low of $1.01.
In the last year, Redhill Biopharma(RDHL) shares hit a 52-week high of $8.37 and a 52-week low of $1.01.